The study eases concerns about using fecal transplants in patients with compromised immune systems, for which supporting guidelines and data did not previously exist.
Lead researcher Chioma Ihunnah, MD, of Brown University in Providence, R.I., and her team found the cure rate of C. diff with a single fecal transplant to be 79 percent, which rose to 89 percent after a second transplant.
More Articles on Gastroenterology:
IBD Sufferers Often Have Limited Access to Care
Olympus Medical to Launch Updated Ultrasound Endoscopy Center in November
South Jersey Endoscopy Center Purchases HET System for Hemorrhoid Treatment
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
